AHA files motions as 340B case returns to district court to determine remedy
Following its unanimous victory in the U.S. Supreme Court earlier this summer, AHA yesterday asked the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to immediately stop underpaying certain hospitals that participate in the 340B Drug Pricing Program and promptly repay them for the unlawful cuts since 2018 without penalizing other hospitals.
Related News Articles
Headline
The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a preliminary injunction against the state’s…
Headline
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s…
Headline
The U.S. District Court for the District of Maine today issued an order denying preliminary injunctions requested by AbbVie and Novartis in legal challenges…
Headline
The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical…
Headline
The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s request for a preliminary injunction…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…